Suppr超能文献

合成、分子性质预测及吲哚-乙烯砜衍生物作为新型微管聚合抑制剂的生物评价:以秋水仙碱结合位点为靶点。

Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site.

机构信息

State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, PR China.

State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, PR China.

出版信息

Bioorg Chem. 2019 Apr;85:49-59. doi: 10.1016/j.bioorg.2018.12.015. Epub 2018 Dec 10.

Abstract

Twenty-two novel indole-vinyl sulfone derivatives were designed, synthesized and evaluated as tubulin polymerization inhibitors. The physicochemical and drug-likeness properties of all target compounds were predicted by Osiris calculations. All compounds were evaluated for their antiproliferative activities, among them, compound 7f exhibited the most potent activity against a panel of cancer cell lines, which was 2-7 folds more potent than our previously reported compound 4. Especially, 7f displayed about 8-fold improvement of selective index as compared with compound 4, indicating that 7f might have lower toxicity. Besides, 7f inhibited the microtubule polymerization by binding to the colchicine site of tubulin. Further investigations showed that compound 7f effectively disrupted microtubule network, caused cell cycle arrest at G2/M phase and induced cell apoptosis in K562 cells. Moreover, 7f reduced the cell migration and disrupted capillary-like tube formation in HUVEC cells. Importantly, the in vivo anti-tumor activity of 7f was validated in H22 liver cancer xenograft mouse model without apparent toxicity, suggesting that 7f is a promising anti-tubulin agent for cancer therapy.

摘要

设计、合成并评价了 22 种新型吲哚-乙烯砜衍生物作为微管聚合抑制剂。通过 Osiris 计算预测了所有目标化合物的物理化学和药物相似性性质。评估了所有化合物对一系列癌细胞系的增殖活性,其中化合物 7f 对癌细胞系的抑制活性最强,比我们之前报道的化合物 4 强 2-7 倍。特别是,与化合物 4 相比,7f 的选择性指数提高了约 8 倍,表明 7f 的毒性可能较低。此外,7f 通过与微管蛋白的秋水仙碱结合位点结合抑制微管聚合。进一步的研究表明,化合物 7f 能有效破坏微管网络,使 K562 细胞周期停滞在 G2/M 期,并诱导细胞凋亡。此外,7f 还能减少 HUVEC 细胞的迁移和破坏毛细血管样管形成。重要的是,在 H22 肝癌异种移植小鼠模型中验证了 7f 的体内抗肿瘤活性,且无明显毒性,表明 7f 是一种有前途的用于癌症治疗的抗微管蛋白药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验